Robert T. Abraham
Directeur/Bestuurslid bij Apertor Pharmaceuticals, Inc.
Profiel
Robert T.
Abraham is currently the Associate Director at Duke Comprehensive Cancer Center and the Director at Apertor Pharmaceuticals, Inc. He was previously the Director at Allogene Therapeutics, Inc., SVP and Group Head-Oncology Research & Development at Pfizer Inc., Professor at Sanford Burnham Prebys Medical Discovery Institute and Duke University Medical Center, and Chief Scientific Officer at Vividion Therapeutics, Inc. Abraham holds a doctorate from the University of Pittsburgh and an undergraduate degree from Bucknell University.
Actieve functies van Robert T. Abraham
Bedrijven | Functie | Begin |
---|---|---|
Duke Comprehensive Cancer Center
Duke Comprehensive Cancer Center Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Directeur/Bestuurslid | 01-11-2020 |
Eerdere bekende functies van Robert T. Abraham
Bedrijven | Functie | Einde |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01-12-2019 |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01-06-2005 |
ALLOGENE THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Duke University Medical Center | Corporate Officer/Principal | - |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Robert T. Abraham
University of Pittsburgh | Doctorate Degree |
Bucknell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PFIZER, INC. | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
Duke Comprehensive Cancer Center
Duke Comprehensive Cancer Center Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC. | |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Health Technology |